Tandem Diabetes Care Update On March Recall Of t:connect Mobile App For iOS Devices; Says Under-delivery Of Insulin Because Of Pump Shutdown Can Be Life-threatening Condition
Portfolio Pulse from Benzinga Newsdesk
Tandem Diabetes Care has provided an update on the March recall of its t:connect Mobile App for iOS devices, citing continued issues with insulin pump shutdowns due to battery depletion. The company plans to release a new app version to address these issues. There have been 107 confirmed adverse events, including two hospitalizations.

August 12, 2024 | 8:33 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Tandem Diabetes Care has updated on the March recall of its t:connect Mobile App for iOS devices, citing continued issues with insulin pump shutdowns due to battery depletion. The company plans to release a new app version to address these issues. There have been 107 confirmed adverse events, including two hospitalizations.
The continued issues with the t:connect Mobile App and the associated adverse events, including hospitalizations, are likely to negatively impact investor sentiment and the stock price of Tandem Diabetes Care in the short term. The company's plan to release a new app version may mitigate some concerns, but the immediate impact is expected to be negative.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100